A NON-RANDOMISED, OPEN-LABEL, UNCONTROLLED, MULTI-CENTRE, PHASE IIIB STUDY EVALUATING THE SAFETY AND EFFICACY OF FLUOCINOLONE ACETONIDE 190 MICROGRAMS INTRAVITREAL IMPLANT IN PAEDIATRIC SUBJECTS FROM 6 YEARS TO LESS THAN 18 YEARS WITH RECURRENT NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF THE EYE
Latest Information Update: 28 Jun 2024
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Intermediate uveitis; Panuveitis; Posterior uveitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Alimera Sciences Europe
Most Recent Events
- 09 Mar 2023 New trial record